Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Goodwill (2016 - 2022)

Ascendis Pharma A's Goodwill history spans 7 years, with the latest figure at $4.9 million for Q4 2022.

  • For Q4 2022, Goodwill fell 18.33% year-over-year to $4.9 million; the TTM value through Dec 2022 reached $4.9 million, down 18.33%, while the annual FY2022 figure was $5.1 million, 18.44% down from the prior year.
  • Goodwill for Q4 2022 was $4.9 million at Ascendis Pharma A, down from $6.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $6.8 million in Q4 2020 and bottomed at $3.9 million in Q4 2019.
  • The 5-year median for Goodwill is $4.9 million (2022), against an average of $5.1 million.
  • The largest annual shift saw Goodwill surged 76.2% in 2020 before it fell 18.33% in 2022.
  • A 5-year view of Goodwill shows it stood at $4.0 million in 2018, then dropped by 3.02% to $3.9 million in 2019, then soared by 76.2% to $6.8 million in 2020, then fell by 11.52% to $6.0 million in 2021, then dropped by 18.33% to $4.9 million in 2022.
  • Per Business Quant, the three most recent readings for ASND's Goodwill are $4.9 million (Q4 2022), $6.0 million (Q4 2021), and $6.8 million (Q4 2020).